Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
KPRX
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 37,230 Added 0.22% |
$18,243
$0.49 p/Share
|
May 08
2018 |
|
KPRX
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 0 Added 0.0% |
-
|
May 08
2018 |
|
APPN
|
Abdiel Capital Management, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 44,669 Added 0.38% |
$1,169,434
$26.18 p/Share
|
May 08
2018 |
|
LAUR
|
Apollo Management Holdings Gp, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 771,536 Reduced 1.74% |
$11,032,965
$14.3 p/Share
|
May 07
2018 |
|
KWR
|
D Jeffry Benoliel
VP - MW, Can and Mining |
SELL
Bona fide gift
|
Direct | 140 Reduced 1.2% |
-
|
May 07
2018 |
|
RBB
|
Simon Pang |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 12.78% |
$191,590
$27.37 p/Share
|
May 07
2018 |
|
SIEN
|
Abingworth LLP |
BUY
Open market or private purchase
|
Indirect | 281,482 Added 10.19% |
$3,800,007
$13.5 p/Share
|
May 07
2018 |
|
INSP
|
Orbimed Advisors LLC
Director |
BUY
Conversion of derivative security
|
Direct | 2,131,721 Added 50.0% |
-
|
May 07
2018 |
|
INSP
|
Orbimed Advisors LLC
Director |
BUY
Open market or private purchase
|
Direct | 312,500 Added 11.34% |
$5,000,000
$16.0 p/Share
|
May 07
2018 |
|
AMRS
|
Maxwell (Mauritius) Pte LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 95,162 Reduced 2.88% |
$622,359
$6.54 p/Share
|
May 07
2018 |
|
HTH
|
Alan B White
Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 18,830 Reduced 8.22% |
$425,746
$22.61 p/Share
|
May 07
2018 |
|
LE
|
Edward S Lampert
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 92,631 Reduced 1.61% |
-
|
May 07
2018 |
|
AN
|
Edward S Lampert |
SELL
Other acquisition or disposition
|
Indirect | 59,293 Reduced 1.61% |
-
|
May 07
2018 |
|
SUMR
|
Wynnefield Partners Small Cap Value LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 76,133 Added 3.63% |
$60,906
$0.8 p/Share
|
May 07
2018 |
|
SUMR
|
Wynnefield Partners Small Cap Value LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 162,231 Added 3.38% |
$129,785
$0.8 p/Share
|
May 07
2018 |
|
JASN
|
Wynnefield Partners Small Cap Value LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 4,427 Added 0.31% |
$11,554
$2.61 p/Share
|
May 07
2018 |
|
JASN
|
Wynnefield Partners Small Cap Value LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 9,432 Added 0.29% |
$24,618
$2.61 p/Share
|
May 07
2018 |
|
LAB
|
Levin Capital Strategies, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 44,700 Added 0.4% |
$250,320
$5.6 p/Share
|
May 07
2018 |
|
TPX
|
Rehan Jaffer
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 180,761 Added 2.36% |
$7,926,370
$43.85 p/Share
|
May 07
2018 |
|
WTM
|
Robert Lawrence Seelig
EVP & General Counsel |
SELL
Open market or private sale
|
Direct | 2,946 Reduced 16.89% |
$2,577,750
$875.0 p/Share
|
May 07
2018 |
|
NVT
|
Brian M Baldwin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,130 Added 50.0% |
-
|
May 07
2018 |
|
CINF
|
David P Osborn |
BUY
Open market or private purchase
|
Indirect | 370 Added 2.38% |
$25,959
$70.16 p/Share
|
May 07
2018 |
|
AFG
|
S Craig Lindner
Co-CEO |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 0.81% |
$2,211,000
$110.55 p/Share
|
May 07
2018 |
|
ACGL
|
John D Vollaro |
BUY
Bona fide gift
|
Indirect | 25,490 Added 15.08% |
-
|
May 07
2018 |
|
ACGL
|
John D Vollaro |
BUY
Exercise of conversion of derivative security
|
Direct | 36,000 Added 50.0% |
$831,600
$23.1 p/Share
|
May 07
2018 |
|
ACGL
|
John D Vollaro |
SELL
Bona fide gift
|
Direct | 25,490 Reduced 100.0% |
-
|
May 07
2018 |
|
ACGL
|
John D Vollaro |
SELL
Payment of exercise price or tax liability
|
Direct | 10,510 Reduced 29.19% |
$831,656
$79.13 p/Share
|
May 07
2018 |
|
ACGL
|
W Preston Hutchings
SVP & Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Indirect | 18,000 Added 7.86% |
$415,800
$23.1 p/Share
|
May 07
2018 |
|
ACGL
|
W Preston Hutchings
SVP & Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Indirect | 5,255 Reduced 2.49% |
$415,828
$79.13 p/Share
|
May 07
2018 |
|
AFL
|
William P Bowers
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,477 Added 11.31% |
-
|
May 07
2018 |
|
AFL
|
Toshihiko Fukuzawa
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,477 Added 23.74% |
-
|
May 07
2018 |
|
AFL
|
Robert B Johnson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,477 Added 9.12% |
-
|
May 07
2018 |
|
AFL
|
Thomas J Kenny
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,505 Added 22.37% |
-
|
May 07
2018 |
|
AFL
|
Karole Lloyd
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,477 Added 13.65% |
-
|
May 07
2018 |
|
AFL
|
Joseph L Moskowitz
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,739 Added 8.78% |
-
|
May 07
2018 |
|
AFL
|
Barbara K Rimer
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,477 Added 12.15% |
-
|
May 07
2018 |
|
AFL
|
Katherine Rohrer
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,477 Added 40.33% |
-
|
May 07
2018 |
|
AFL
|
Melvin T Stith
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,477 Added 9.58% |
-
|
May 07
2018 |
|
INSP
|
Medtronic Inc
> 10% Shareholder |
BUY
Conversion of derivative security
|
Direct | 358,690 Added 31.84% |
-
|
May 07
2018 |
|
TMUS
|
G Michael Sievert
President and CEO |
SELL
Open market or private sale
|
Direct | 3,056 Reduced 0.65% |
$173,978
$56.93 p/Share
|
May 07
2018 |
|
AGLE
|
Novartis Bioventures LTD |
SELL
Open market or private sale
|
Direct | 15,548 Reduced 0.67% |
$157,190
$10.11 p/Share
|
May 07
2018 |
|
CVX
|
Michael K Wirth
Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 130,000 Added 50.0% |
$9,061,000
$69.7 p/Share
|
May 07
2018 |
|
CVX
|
Michael K Wirth
Chairman and CEO |
SELL
Open market or private sale
|
Direct | 130,000 Reduced 100.0% |
$16,640,000
$128.0 p/Share
|
May 07
2018 |
|
CVX
|
Joseph C Geagea
Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 12,000 Added 47.56% |
$836,400
$69.7 p/Share
|
May 07
2018 |
|
CVX
|
Joseph C Geagea
Executive Vice President |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 90.68% |
$1,536,480
$128.04 p/Share
|
May 07
2018 |
|
CRSP
|
Bradley J Ph D Bolzon
Director |
SELL
Open market or private sale
|
Indirect | 119,709 Reduced 4.08% |
$6,080,020
$50.79 p/Share
|
May 07
2018 |
|
CRSP
|
Thomas Woiwode
Director |
SELL
Open market or private sale
|
Indirect | 119,709 Reduced 4.08% |
$6,080,020
$50.79 p/Share
|
May 07
2018 |
|
ADI
|
Margaret K Seif
SVP, CPO and CLO |
BUY
Exercise of conversion of derivative security
|
Direct | 7,000 Added 18.66% |
$314,790
$44.97 p/Share
|
May 07
2018 |
|
ADI
|
Margaret K Seif
SVP, CPO and CLO |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 22.94% |
$629,020
$89.86 p/Share
|
May 07
2018 |
|
VC
|
Sachin Lawande
CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct | 2,500 Added 7.14% |
$182,450
$72.98 p/Share
|
May 07
2018 |